1,2 dioleoyl sn glycero 3 phosphoethanolamine

DOPE (DOPE) is a neutral helper lipid for cationic liposomes.It is used in combination with cationic phospholipids to increase efficiency during DNA transfection studies as a non-viral method of gene delivery.

18:1 Dimethyl PE (1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N,N-dimethyl) is a type of phospholipid utilized in life science research, often serving as a biomaterial or organic compound.

18:1 PEG350 PE is a PEG lipid functional end group used in synthesizing liposomes (LPs) that is designed for the creation of conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) can couple with other biomolecules through biotin modifications and carboxyl terminals. Functionalized nanoparticles are employed for targeted labeling of specific cell proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, facilitating fluorescence-based imaging and sensing applications.

18:1 PEG550 PE is utilized as a PEG lipid functional end group for synthesizing liposomes (LPs) and designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs), featuring biotin modifications and carboxyl terminals, facilitate further coupling with other biomolecules. These functionalized nanoparticles are employed for targeted labeling of specific cellular proteins. Utilizing streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling fluorescence-based imaging and sensing applications.

18:1 PEG1000 PE is a PEG-lipid functional end group used in the synthesis of liposomes (LPs) and for designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) can be further coupled with other biomolecules through biotin modification and a carboxyl end. Functionalized nanoparticles are applicable for the targeted labeling of specific cell proteins. Using streptavidin as a linker, biotin-modified PEG-lipid conjugated polymer nanoparticles can bind with biotinylated antibodies on cell surface receptors, facilitating fluorescence-based imaging and sensing applications.

18:1 PEG3000 PE is a PEG lipid functional terminal group utilized in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Liposome nanoparticles (LNPs), modified with biotin and carboxy terminals, can couple with other biomolecules. Such functionalized nanoparticles are employed for targeted labeling of specific cell proteins. Using streptavidin as a linker, the biotinylated PEG lipid-conjugated polymer nanoparticles can bind with biotinylated antibodies on cell surface receptors, providing utility in fluorescence-based imaging and sensing.

18:1 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for designing conjugated polymer nanoparticles. These lipid nanoparticle complexes (LNPs), with biotin modification and carboxyl termini, can further couple with other biomolecules. The functionalized nanoparticles can target and label specific cell proteins. Using streptavidin as a linker, the biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling fluorescence-based imaging and sensing applications.

DOPE-DOTA sodium is a chelating lipid that serves as a crucial contrast agent in magnetic resonance imaging (MRI). It is applicable in studies related to cancer, blood-brain barrier disruption, aneurysms or plaque buildup, arthritis inflammation, as well as liver function and lesions.